FEMAX | FSSNX | FEMAX / FSSNX | |
Total Expense Ratio | 1.20 | 0.03 | 4,800% |
Annual Report Gross Expense Ratio | 2.27 | 0.03 | 9,080% |
Fund Existence | 3 years | 14 years | - |
Gain YTD | -3.277 | -5.166 | 63% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 55M | 24.9B | 0% |
Annual Yield % from dividends | 0.19 | 1.10 | 18% |
Returns for 1 year | 1.10 | 4.63 | 24% |
Returns for 3 years | N/A | 29.17 | - |
Returns for 5 years | N/A | 58.19 | - |
Returns for 10 years | N/A | 63.25 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TNVDX | 10.40 | -0.05 | -0.51% |
1290 Loomis Sayles Multi-Asset Income I | |||
CGIIX | 47.20 | -0.48 | -1.01% |
Calamos Growth & Income I | |||
BIVSX | 17.23 | -0.18 | -1.03% |
Invenomic Super Institutional | |||
PRBLX | 61.89 | -0.86 | -1.37% |
Parnassus Core Equity Investor | |||
GSCIX | 40.64 | -0.73 | -1.76% |
abrdn US Small Cap Equity Inst |